![]() |
|
|
Vol. 298, Issue 2, 644-650, August 2001
Department of Pharmacology, University of Oxford, Oxford, United
Kingdom
2-Hydroxycarbazole, a compound structurally related to the
Ca2+-mobilizing marine toxin
9-methyl-7-bromoeudistomin, has recently been proposed to
activate both type 1 and type 2 ryanodine receptors in skeletal and
cardiac muscle, respectively. This study was undertaken to evaluate the
activity of this compound in the sea urchin egg homogenate, a model
system used to characterize intracellular Ca2+ mobilization
mechanisms. 2-Hydroxycarbazole was found to potently release
Ca2+ in a concentration-dependent manner via a specific
mechanism displaying apparent desensitization. Use of selective
inhibitors of the Ca2+-mobilizing messengers inositol
1,4,5-trisphosphate, cyclic adenosine diphosphate ribose, and nicotinic
acid adenine dinucleotide phosphate, as well as desensitization of
homogenates to each of these molecules, failed to inhibit the response
to 2-hydroxycarbazole. However, the response to 2-hydroxycarbazole was
competitively antagonized by caffeine. Investigation of the
Ca2+ stores accessed by 2-hydroxycarbazole revealed
Ca2+ release from a thapsigargin-insensitive pool. Finally,
2-hydroxycarbazole failed to enhance [3H]ryanodine
binding, suggesting the operation of a nonryanodine receptor mechanism.
These results demonstrate that 2-hydroxycarbazole is acting to modulate
a Ca2+ release mechanism with distinct pharmacological
properties to those previously reported in the sea urchin egg.